Two proprietary Chinese medicines used to treat COVID-19

2020-04-20 318Second

      The novel coronavirus injection produced by Tianjin red sun pharmaceutical company has been approved for use in severe and severe systemic inflammatory response syndrome (SARS) or / or multiple organ failure in new coronavirus pneumonia, and the dosage and dosage are 2 times a day. Lianhuaqingwen capsule (granule) produced by Yiling Pharmaceutical Co., Ltd. was approved to be used for fever, cough and asthenia caused by new coronavirus pneumonia of light and common type, with a course of 7-10 days.